Gene · 23607
CD2AP: CD2 associated protein
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CD2AP: CD2 associated protein. Genes, record 23607. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/23607
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9Y5K6 | CD2-associated protein | 639 | 12 | Ensembl, GeneID, HGNC |
Source UniProt
Patents19
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 40524 | Q9Y5K6 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 7688 | Q9Y5K6 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 7688 | Q9Y5K6 | Espacenet |
| JP 2025062601 A | 2025-04-14 | 14 | Q9Y5K6 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 13060 | Q9Y5K6 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 116031 | Q9Y5K6 | Espacenet |
| JP 2022523514 A | 2022-04-25 | 14 | Q9Y5K6 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 1818 | Q9Y5K6 | Espacenet |
| US 11002729 B2 | 2021-05-11 | 2 | Q9Y5K6 | Espacenet |
| WO 2020043864 A1 | 2020-03-05 | 408 | Q9Y5K6 | Espacenet |
1 to 10 of 19
See all 19 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,872
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CD2AP papers | Newest fiscal year |
|---|---|---|---|
| U24AG021886 | National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) | 71 | 2025 |
| P01AG019724 | Frontotemporal Dementia: Genes, Images, and Emotions | 19 | 2025 |
| P01AG026276 | Antecedent Biomarkers for Alzheimer Disease: The Adult Children Study | 17 | 2025 |
| U24AG041689 | THE NIA GENETICS OF ALZHEIMER'S DISEASE DATA STORAGE SITE | 10 | 2025 |
| U24AG056270 | National Institute on Aging Alzheimer's Disease Family-Based Study (NIA-AD FBS) | 9 | 2025 |
| R01NS017950 | Precursors of Stroke Incidence and Prognosis | 8 | 2025 |
| U19AG024904 | Alzheimer's Disease Neuroimaging Initiative (ADNI4) | 8 | 2025 |
| P30AG066444 | Alzheimer's Disease Research Center | 5 | 2025 |
| P30AG066462 | Alzheimer's Disease Research Center | 5 | 2025 |
| P30AG072975 | Rush Alzheimer's Disease Research Center | 5 | 2025 |
1 to 10 of 1,872Source NIH's project files
See all 1,872 nih grantsPapers1,907
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tau dysfunction in alzheimer's disease: molecular and cellular mechanisms, genetic modulation, and therapeutic perspectives. | Mol Biol Rep | 2026 | 42593621 | PubTator, text mining | PubMed |
| Inhibitory TIGIT signaling is dependent on T cell receptor activation. | Cell Rep | 2026 | 42560817 | PubTator, text mining | PubMed |
| Alphavirus nsP3 as a multifunctional orchestrator of virus-host interplay. | J Virol | 2026 | 42294907 | PubTator, text mining | PubMed |
| The Phosphoproteomic Landscape of CD2AP: A Comprehensive Review of Kinase Networks and Disease Implications. | OMICS | 2026 | 42159329 | PubTator, text mining | PubMed |
| Shared Genetic Architecture Between Kidney Function and Alzheimer Disease Across Ancestries. | medRxiv | 2026 | 42006785 | PubTator, text mining | PubMed |
| Recurrence of focal segmental glomerulosclerosis: An updated review of pathophysiology, biomarkers, and therapeutic strategies. | Cell Transplant | 2026 | 41906863 | PubTator, text mining | PubMed |
| Programmed cell death: a promising management for Alzheimer's disease. | Apoptosis | 2026 | 41904723 | PubTator, text mining | PubMed |
| Extracellular Vesicles Associated Metabolites as Intercellular Signalling Mediators in Disease and Therapy. | Metabolites | 2026 | 41893356 | PubTator, text mining | PubMed |
| Nephroprotective Effects of Vanillic Acid on Bortezomib-Induced Renal Injury: Role of Oxidative Stress, Mitochondrial Dysfunction, Apoptosis and miR-204/Nephrin/Podocin/CD2AP Axis. | Basic Clin Pharmacol Toxicol | 2026 | 41862410 | PubTator, text mining | PubMed |
| Circular RNAs in sepsis-induced acute lung injury: emerging mechanisms and therapeutic potential. | Front Immunol | 2026 | 41789098 | PubTator, text mining | PubMed |
1 to 10 of 1,907
See all 1,907 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/23607
GET https://conductscience.org/api/genes/v1/23607/patents